Risk of other Cancers in Families with Melanoma: Novel Familial Links

[1]  K. Nielsen,et al.  Germline CDKN2A Mutation Status and Survival in Familial Melanoma Cases. , 2016, Journal of the National Cancer Institute.

[2]  M. Hyrcza,et al.  Gene of the month: BAP1 , 2016, Journal of Clinical Pathology.

[3]  K. Hemminki,et al.  Location of metastases in cancer of unknown primary are not random and signal familial clustering , 2016, Scientific Reports.

[4]  K. Hemminki,et al.  Search for familial clustering of multiple myeloma with any cancer , 2016, Leukemia.

[5]  N. Hayward,et al.  Melanoma genetics , 2015, Journal of Medical Genetics.

[6]  K. Hemminki,et al.  Population Landscape of Familial Cancer , 2015, Scientific Reports.

[7]  Marko Hočevar,et al.  Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma , 2015, Nature Genetics.

[8]  K. Hemminki,et al.  Multiple primary (even in situ) melanomas in a patient pose significant risk to family members. , 2014, European journal of cancer.

[9]  K. Hemminki,et al.  The population impact of familial cancer, a major cause of cancer , 2014, International journal of cancer.

[10]  K. Hemminki,et al.  Effect of a detailed family history of melanoma on risk for other tumors: a cohort study based on the nationwide Swedish Family-Cancer Database. , 2014, The Journal of investigative dermatology.

[11]  J. Mascarenhas,et al.  Pathogenesis and management of acute myeloid leukemia that has evolved from a myeloproliferative neoplasm , 2014, Current opinion in hematology.

[12]  Thomas Krausz,et al.  BAP1 and cancer , 2013, Nature Reviews Cancer.

[13]  K. Hemminki,et al.  Do discordant cancers share familial susceptibility? , 2012, European journal of cancer.

[14]  L. Cannon-Albright,et al.  A comprehensive survey of cancer risks in extended families , 2012, Genetics in Medicine.

[15]  J. Rosai.  The origin of neuroendocrine tumors and the neural crest saga , 2011, Modern Pathology.

[16]  K. Hemminki,et al.  Familial risks in cancer of unknown primary: tracking the primary sites. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  R. Reznek,et al.  Cancer of unknown primary site. , 2008, Clinical medicine.

[18]  S. Puig,et al.  Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents , 2006, Journal of Medical Genetics.

[19]  K. Czene,et al.  Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family‐cancer database , 2002, International journal of cancer.

[20]  Acknowledgements , 1992, Experimental Gerontology.

[21]  Gene of the month. , 1996, Nature biotechnology.